
Meridian Bioscience VIVO
Quarterly report 2022-Q4
added 02-09-2023
Meridian Bioscience EV/EBITDA Ratio 2011-2026 | VIVO
Annual EV/EBITDA Ratio Meridian Bioscience
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 7.53 | 10.3 | 9.05 | 12.8 | 11.3 | 10.7 | 10.5 | 10.4 | 12.5 | 10.9 | 11.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 12.8 | 7.53 | 10.7 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
Agilent Technologies
A
|
27.4 | $ 118.99 | -0.65 % | $ 36.2 B | ||
|
Burning Rock Biotech Limited
BNR
|
-1.51 | $ 19.95 | -2.97 % | $ 215 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
-100 | $ 21.86 | 24.42 % | $ 1.16 B | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 524.79 | 1.21 % | $ 15.1 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
NeoGenomics
NEO
|
-33.5 | $ 8.21 | -5.41 % | $ 1.05 B | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 9.34 | -0.85 % | $ 2.03 B | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | - | - | $ 19.8 B | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
55.6 | $ 29.04 | -0.17 % | $ 20 B | ||
|
Co-Diagnostics
CODX
|
3.62 | $ 1.4 | -1.41 % | $ 1.86 M | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 24.41 | -0.85 % | $ 678 M | ||
|
Senseonics Holdings
SENS
|
-13.8 | $ 6.78 | -1.74 % | $ 283 M | ||
|
Soleno Therapeutics
SLNO
|
0.12 | $ 52.61 | 0.07 % | $ 2.67 B | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
Neuronetics
STIM
|
-1.45 | $ 1.44 | 3.24 % | $ 95 M | ||
|
Charles River Laboratories International
CRL
|
22 | $ 181.44 | 0.49 % | $ 8.99 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Danaher Corporation
DHR
|
20.1 | $ 194.37 | -1.9 % | $ 139 B | ||
|
Thermo Fisher Scientific
TMO
|
19.3 | $ 521.66 | -1.88 % | $ 197 B | ||
|
Interpace Biosciences
IDXG
|
-6.02 | $ 2.06 | -6.51 % | $ 9.11 M | ||
|
Trinity Biotech plc
TRIB
|
12.6 | $ 0.7 | 0.07 % | $ 61.9 M | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 56.77 | -1.48 % | $ 3.4 B | ||
|
Illumina
ILMN
|
70.5 | $ 132.04 | -0.17 % | $ 21 B | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 16.2 | 0.19 % | $ 490 M | ||
|
Guardant Health
GH
|
-28.8 | $ 85.68 | 0.97 % | $ 10.7 B | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-2.25 | $ 2.85 | -2.73 % | $ 92.5 K | ||
|
Biomerica
BMRA
|
-6.24 | $ 2.2 | 4.27 % | $ 5.05 M | ||
|
Waters Corporation
WAT
|
24.6 | $ 323.1 | -0.95 % | $ 19.2 B | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 118.29 | 1.54 % | $ 9.76 B | ||
|
Laboratory Corporation of America Holdings
LH
|
8.7 | $ 268.78 | 0.77 % | $ 22.4 B | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
Celcuity
CELC
|
-2.38 | $ 124.59 | 0.91 % | $ 5.83 B | ||
|
Myriad Genetics
MYGN
|
-17.2 | $ 5.15 | -0.87 % | $ 477 M | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 83.57 | -0.44 % | $ 5.64 B | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 193.81 | 1.25 % | $ 21.5 B |